InnoPharmax Inc. (TPEX:4172)

InnoPharmax Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	166.73	39.36	40.53	90.51	181.4
Short-Term Investments	114.5	100.3	55.85	96.76	60.49
Cash & Short-Term Investments	281.23	139.66	96.37	187.26	241.89
Cash Growth	101.37%	44.91%	-48.54%	-22.58%	43.66%
Accounts Receivable	4.53	6.96	-	-	11.72
Other Receivables	0.47	0.82	0.57	4.03	4.32
Receivables	5	7.78	0.57	4.03	16.04
Inventory	19.33	25.53	30.5	16.12	49.23
Prepaid Expenses	1.47	3.38	1.1	1.92	1.23
Other Current Assets	13.26	12.65	8.2	-	3.48
Total Current Assets	320.29	188.99	136.74	209.33	311.87
Property, Plant & Equipment	8.59	13.77	19.57	13.77	20.57
Long-Term Investments	261.21	269.14	278.43	283.97	299.39
Other Intangible Assets	6.22	6.72	8.85	9.75	12.62
Long-Term Accounts Receivable	-	6.09	6.09	6.09	-
Long-Term Deferred Tax Assets	19.4	21.72	21.72	21.72	21.72
Other Long-Term Assets	17.35	17.75	17.92	11.53	14.02
Total Assets	633.06	524.2	489.31	556.16	680.18
Accounts Payable	2.4	6.7	0.84	0.84	37.02
Accrued Expenses	0	0	0.23	0.04	0.06
Short-Term Debt	10	11.5	23.27	-	20
Current Portion of Leases	4.57	4.48	4.42	4.5	4.42
Current Unearned Revenue	2.44	0.18	0.18	0.18	0.18
Other Current Liabilities	9.98	11.09	10.19	8.66	141.45
Total Current Liabilities	29.4	33.95	39.13	14.22	203.12
Long-Term Leases	0.82	5.39	9.86	1.08	5.49
Other Long-Term Liabilities	-	9.32	9.32	9.32	-
Total Liabilities	30.22	48.65	58.31	24.61	208.61
Common Stock	1,076	949.97	868.36	867.19	765.46
Additional Paid-In Capital	100.43	34.17	0.77	52.86	-
Retained Earnings	-572.96	-507.84	-437.48	-386.89	-293.98
Comprehensive Income & Other	-0.44	-0.75	-0.66	-1.61	0.09
Shareholders' Equity	602.85	475.55	431	531.54	471.57
Total Liabilities & Equity	633.06	524.2	489.31	556.16	680.18
Total Debt	15.39	21.36	37.56	5.57	29.9
Net Cash (Debt)	265.84	118.29	58.82	181.69	211.99
Net Cash Growth	124.73%	101.12%	-67.63%	-14.29%	57.46%
Net Cash Per Share	2.73	1.28	0.68	2.10	2.77
Filing Date Shares Outstanding	107.58	95	86.84	86.72	76.55
Total Common Shares Outstanding	107.58	95	86.84	86.72	76.55
Working Capital	290.89	155.05	97.61	195.11	108.74
Book Value Per Share	5.60	5.01	4.96	6.13	6.16
Tangible Book Value	596.62	468.82	422.15	521.8	458.95
Tangible Book Value Per Share	5.55	4.94	4.86	6.02	6.00
Machinery	35.67	35.14	34.74	36.97	35.52
Leasehold Improvements	0.66	0.66	0.66	0.66	0.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.